Although enlargement of corticotroph adenomas may be a concern with the use of steroidogenesis inhibitors, it is difficult to determine whether any observed change in tumor size is related to loss of ACTH-cortisol feedback or reflects the natural history of progressive or recurrent disease (32). Here, POMC is linked to ACTH-producing pituitary gland adenoma.